^
No biomarker
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A1
RET mutation
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
A1
No biomarker
Thyroid Gland Medullary Carcinoma
vandetanib
Sensitive
:
A1
RET mutation
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
A1
No biomarker
Thyroid Gland Medullary Carcinoma
dacarbazine
Sensitive
:
A2
No biomarker
Thyroid Gland Medullary Carcinoma
denosumab
Sensitive
:
A2
No biomarker
Thyroid Gland Medullary Carcinoma
cabozantinib tablet
Sensitive
:
A2
TMB-H
Thyroid Gland Medullary Carcinoma
pembrolizumab
Sensitive
:
A2
RET M918T
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
RAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
KRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
B
NRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
B
KRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
B
RET mutation
Thyroid Gland Medullary Carcinoma
TPX-0046
Sensitive
:
C2
RET mutation
Thyroid Gland Medullary Carcinoma
BOS-172738
Sensitive
:
C2
RET positive
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C2
RET V804*
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
C3
RET C634*
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
C3
RET M918T
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
C3
RET C634R
Thyroid Gland Medullary Carcinoma
sorafenib
Sensitive
:
C3
RET M918T
Thyroid Gland Medullary Carcinoma
sorafenib
Sensitive
:
C3
RET V804M
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C3
RET M918T
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C3
RET V804L
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C3
RET mutation
Thyroid Gland Medullary Carcinoma
RET inhibitor
Sensitive
:
C3
RET V804M + RET M918T + RET G810 + RET Y806
Thyroid Gland Medullary Carcinoma
selpercatinib
Resistant
:
C4
NF1 mutation
Thyroid Gland Medullary Carcinoma
vandetanib
Sensitive
:
C4
RET M918T
Thyroid Gland Medullary Carcinoma
everolimus + vandetanib
Sensitive
:
C4
ATM S978fs*12
Thyroid Gland Medullary Carcinoma
everolimus + vandetanib
Sensitive
:
C4
ATM L804fs*4
Thyroid Gland Medullary Carcinoma
everolimus + vandetanib
Sensitive
:
C4
RET C620R
Thyroid Gland Medullary Carcinoma
everolimus
Sensitive
:
C4
RET M918T
Thyroid Gland Medullary Carcinoma
everolimus
Sensitive
:
C4